In this update we added a new monograph for APREPITANT.

We also added new stability information to the monographs for CABAZITAXEL, FOSAPREPITANT DIMEGLUMINE, OMADACYCLINE, and PEMBROLIZUMAB.

New compatibility information was added to the existing drug monographs for COLISTIMETHATE SODIUM, AZTREONAM, CEFOTAXIME SODIUM, CEFTRIAXONE, CO-TRIMOXAZOLE, DAPTOMYCIN, FLUCONAZOLE, FUROSEMIDE, HEPARIN SODIUM, HYDROCORTISONE SODIUM SUCCINATE, IBUPROFEN, INSULIN, REGULAR, KETOPROFEN, LEVETIRACETAM, LINEZOLID, MAGNESIUM SULFATE, MORPHINE SULFATE, NAFCILLIN SODIUM, OMADACYCLINE, ONDANSETRON HYDROCHLORIDE, PALONOSETRON HYDROCHLORIDE, PIPERACILLIN AND TAZOBACTAM, POTASSIUM CHLORIDE, POTASSIUM PHOSPHATE, PROTAMINE SULFATE, SODIUM PHOSPHATE, TENECTEPLASE, THIAMINE HYDROCHLORIDE and TRAMADOL HYDROCHLORIDE.